Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 386

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice

Open access
BarathManiKanth, Selvaraj, Kalishwaralal, Kalimuthu, Sriram, Muthuirulappan, Pandian, SureshBabu Ram Kumar, Youn, Hyung-seop, Eom, SooHyun, Gurunathan, Sangiliyandi·2010·Journal of Nanobiotechnology

Abstract

Background: Oxidative stress is imperative for its morbidity towards diabetic complications, where abnormal metabolic milieu as a result of hyperglycemia, leads to the onset of several complications. A biological antioxidant capable of inhibiting oxidative stress mediated diabetic progressions; during hyperglycemia is still the need of the era. The current study was performed to study the effect of biologically synthesized gold nanoparticles (AuNPs) to control the hyperglycemic conditions in streptozotocin induced diabetic mice. Results: The profound control of AuNPs over the anti oxidant enzymes such as GSH, SOD, Catalase and GPx in diabetic mice to normal, by inhibition of lipid peroxidation and ROS generation during hyperglycemia evidence their anti-oxidant effect during hyperglycemia. The AuNPs exhibited an insistent control over the blood glucose level, lipids and serum biochemical profiles in diabetic mice near to the control mice provokes their effective role in controlling and increasing the organ functions for better utilization of blood glucose. Histopathological and hematological studies revealed the non-toxic and protective effect of the gold nanoparticles over the vital organs when administered at dosage of 2.5 mg/kilogram.body.weight/day. ICP-MS analysis revealed the biodistribution of gold nanoparticles in the vital organs showing accumulation of AuNPs in the spleen comparatively greater than other organs. Conclusion: The results obtained disclose the effectual role of AuNPs as an anti-oxidative agent, by inhibiting the formation of ROS, scavenging free radicals; thus increasing the anti-oxidant defense enzymes and creating a sustained control over hyperglycemic conditions which consequently evoke the potential of AuNPs as an economic therapeutic remedy in diabetic treatments and its complications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1477-3155-8-16

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Research works printed but not linked: 13

  1. Ruggiero D, Lecomte M, Michoud E, Lagarde M, Wiernsperger N: Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabetes Metab. 1997, 23: 30-42.
  2. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S: l:Antiangiogenic properties of gold nanoparticles. Clin Cancer Res. 2005, 11: 3530-3534. 10.1158/1078-0432.CCR-04-2482. · DOI · Paper page
  3. Kalishwaralal K, Deepak V, Pandian SRK, Gurunathan S: Biological synthesis of gold nanocubes using Bacillus licheniformis. Bioresour Technol. 2009, 100: 5356-5358. 10.1016/j.biortech.2009.05.051. · DOI
  4. Singha SJ, Bhattacharya H, Datta AK, Dasgupta : Anti-glycation activity of gold nanoparticles. Nanomedicine: NBM. 2009, 5: 21-29. · doi:10.1016/j.nano.2008.06.005
  5. Popper H: Cholestasis. Annu Rev Med. 1968, 19: 39-56. 10.1146/annurev.me.19.020168.000351. · doi:10.1146/annurev.me.19.020168.000351
  6. Ruggiero D, Lecomte M, Michoud E, Lagarde M, Wiernsperger N: Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabetes Metab. 1997, 23: 30-42.
  7. Svedberg EB, Ahner J, Shukla N, Ehrman SH, Schilling K: FePt nanoparticle hydrodynamic size and densities from the polyol process as determined by analytical ultracentrifugation. Nanotechnology. 2005, 16: 953-956. 10.1088/0957-4484/16/6/056. · doi:10.1088/0957-4484/16/6/056
  8. Moghimi SM: Exploiting Bone-Marrow Microvascular Structure for Drug-Delivery and Future Therapies. Adv Drug Deliv Rev. 1995, 17: 61-73. 10.1016/0169-409X(95)00041-5. · doi:10.1016/0169-409x(95)00041-5
  9. Svedberg EB, Ahner J, Shukla N, Ehrman SH, Schilling K: FePt nanoparticle hydrodynamic size and densities from the polyol process as determined by analytical ultracentrifugation. Nanotechnology. 2005, 16: 953-956. 10.1088/0957-4484/16/6/056. · doi:10.1088/0957-4484/16/6/056
  10. King GL, Loeken MR: Hyperglycemia-induced oxidative stress in diabetic complications. Histochem. Cell Biol. 2004, 122: 333-338.
  11. Kalishwaralal K, Deepak V, Pandian SRK, Gurunathan S: Biological synthesis of gold nanocubes using Bacillus licheniformis. Bioresour Technol. 2009, 100: 5356-5358. 10.1016/j.biortech.2009.05.051. · DOI
  12. Kalishwaralal K, Gopalram S, Vaidyanathan R, Deepak V, Pandian SRK, Gurunathan S: Optimization of α-amylase production for the green synthesis of gold nanoparticles. Colloid Surf B. 2010, 77: 174-80. 10.1016/j.colsurfb.2010.01.018. · doi:10.1016/j.colsurfb.2010.01.018
  13. Marquis BJ, Love SA, Braun KL, Haynes CL: Analytical methods to assess nanoparticle toxicity. Analyst. 2009, 134: 425-439. 10.1039/b818082b. · DOI · Paper page

Cited by

See all 386

Metadata

Authors
BarathManiKanth, S., Kalishwaralal, K., Sriram, M., Pandian, S. R. K., Youn, H.-S., Eom, S., & Gurunathan, S.
Venue
Journal of Nanobiotechnology
Published
2010-07-14
Volume
8
Issue
1
Pages
16-16
ISSN
1477-3155 (ISSN-L)
OpenAlex
W2061823587
Cited by
386
References
58
FWCI
11.89
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. https://app.cochat.ai/papers/10.1186/1477-3155-8-16
The paper
BarathManiKanth, S., Kalishwaralal, K., Sriram, M., Pandian, S. R. K., Youn, H.-S., Eom, S., & Gurunathan, S. (2010). Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. Journal of Nanobiotechnology. https://doi.org/10.1186/1477-3155-8-16

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.